Supply of PVMS Drugs for Directorate of Procurement (Navy) Islamabad

The Directorate of Procurement (Navy), Islamabad, invites sealed bids from original manufacturers, authorized distributors, suppliers, and contractors registered with income tax and sales tax departments for the supply of PVMS Drugs as per the detailed schedule in DP-2 form. This procurement is for the Pakistan Navy Medical Stores Depot and related medical facilities in Islamabad and Karachi. Items being procured: - Fluconazole 150 mg Tablets (45,000 units) - Teicoplanin 200 mg Vials (1,500 units) - Vancomycin 500 mg Vials (5,000 units) - Vancomycin 1 gm Vials (6,000 units) - Clotrimazole 1% Tubes (10,000 units) - Acyclovir 400 mg Tablets/Capsules (60,000 units) - Acyclovir 500 mg Infusion (10,000 units) - Dexamethasone 4 mg/ml Ampoules/Vials (90,000 units) - Hydrocortisone Sodium Succinate 100 mg Vials (80,000 units) - Methyl Prednisolone Sodium Succinate 500 mg Ampoules/Vials (3,000 units) - Methyl Prednisolone Sodium Succinate 1 gm Ampoules/Vials (2,000 units) - Prednisolone 5 mg Tablets/Capsules (900,000 units) - Betahistine 8 mg Tablets/Capsules (450,000 units) - Betahistine 16 mg Tablets/Capsules (500,000 units) - Chlorpheniramine Syrup/Suspension 2 mg/5 ml (25,000 units) - Desloratadine 5 mg Tablets/Capsules (150,000 units) - Levocetirizine Syrup/Suspension 2.5 mg/5 ml (30,000 units) - Levocetirizine 5 mg Tablets/Capsules (200,000 units) - Loratadine Syrup/Suspension 5 mg/5 ml (160,000 units) - Loratadine 10 mg Tablets/Capsules (2,500,000 units) - Artemether + Lumefantrine Syrup/Suspension 15 mg + 90 mg/5 ml (8,000 units) - Artemether + Lumefantrine 80/480 mg Tablets/Capsules (160,000 units) - Thyroxine 50 mcg Tablets/Capsules (1,000,000 units) - Clomiphene Citrate 50 mg Tablets/Capsules (30,000 units) - Nor-Adrenaline 2 mg Ampoules/Vials (25,000 units) - Norethisterone 5 mg Tablets/Capsules (300,000 units) - Synthetic Oxytocin 5 IU/1 ml Ampoules/Vials (120,000 units) The technical scope includes supply of brand new medicines conforming to PVMS/NIV specifications with minimum shelf life requirements, proper packaging, and compliance with national and international standards. Delivery is scheduled from 1st July 2027 to 30th June 2028 on a supply order basis. Inspection will be conducted by Pakistan Navy Medical Stores Depot at Karachi and Islamabad. Firms must be registered or willing to register with DGDP and comply with all tax and regulatory requirements including FBR ATL registration. Earnest money must be submitted as per category with a maximum ceiling depending on firm registration status. Bids must be submitted in sealed envelopes with separate technical and commercial offers following the Single Stage Two Envelope procedure. The tender will be opened on 27 October 2026 at 1100 hours at the Directorate of Procurement (Navy), Islamabad. Late bids will not be accepted. A practical tip for bidders: Ensure your technical offer strictly follows the format and includes all required documents such as DGDP registration, GMP certificates, analysis reports, and compliance with the evaluation criteria to avoid rejection at the technical scrutiny stage. This tender offers a significant opportunity for pharmaceutical suppliers to engage with the Pakistan Navy for a large-scale supply contract in Islamabad.